Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
AUTOR(ES)
Briggs, Andrew
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955018Documentos Relacionados
- Does intensified cholesterol lowering provide greater protection from cardiovascular events among patients with stable coronary artery disease?
- Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial
- Periodontal disease and inflammatory blood cytokines in patients with stable coronary artery disease
- Cost-effectiveness of coronary artery bypass surgery in octogenarians.
- “Polypill” to fight cardiovascular disease: Cost effectiveness of statins for primary prevention of cardiovascular events is questionable